Brawn Biotech Ltd.
| BSE: 530207 | Sector: Others |
| NSE: N.A. | ISIN Code: INE899B01015 |
| BSE 00:00 | 26 Feb | 24.80 |
0.10 (0.40%) |
OPEN
23.50 |
HIGH
25.50 |
LOW
23.50 |
| NSE 05:30 | 01 Jan | Brawn Biotech Ltd |
| OPEN | 23.50 |
| PREVIOUS CLOSE | 24.70 |
| VOLUME | 98 |
| 52-Week high | 32.00 |
| 52-Week low | 16.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 7 |
| Buy Price | 23.55 |
| Buy Qty | 57.00 |
| Sell Price | 24.80 |
| Sell Qty | 160.00 |
Brawn Biotech Ltd. (BRAWNBIOTECH) - Company Information
Brawn Biotech Ltd
BRAWN with its inception barely 26 years back (1985) has today evolved into a fully integrated healthcare group marking its presence in India and dotting various major markets across the globe. BRAWN is proud to possess product registration with major health and govt. institutions throughout India and in many other countries worldwide. Headed and represented by a team of skilled industry experts w...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | B R Gupta | ||||||
| Director : | Brij Bala Gupta. | ||||||
| Independent Director : | Subhash Chander | ||||||
| Independent Director : | Kanta Takkar | ||||||
| AUDITOR : | Rajiv Udai & Associates | ||||||
| IND NAME : | Trading | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 4B Asaf Ali Road II Floor, Delhi Stock Exchange Building,New Delhi,New Delhi-110002 | |||||||
| Ph : | |||||||
| WEBSITE : http://www.brawnpharma.com | |||||||
| E-mail : solution@brawnpharma.com | |||||||
Quick Links for Brawn Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
